Literature DB >> 14670181

Isolation of a colon tumor specific binding peptide using phage display selection.

Kimberly A Kelly1, David A Jones.   

Abstract

Colorectal cancer is the third most common malignancy in the United States. Improved detection sensitivity of early colorectal neoplasms would have important clinical applications. Herein, we report on using phage display to generate peptide libraries that detect colon carcinoma tissues. To accomplish this, we employed positive selection of a peptide-bearing phage library on poorly differentiated colon carcinoma cells (HT29) and combined this with negative selection of the phage library on well-differentiated colon carcinoma cells (HCT116). Analysis of the resulting library identified a nine-amino-acid, disulfide-constrained peptide, CPIEDRPMC (RPMrel), that stained HT29 colon carcinoma cells. Immunohistochemical staining using FITC-conjugated RPMrel peptide also showed binding of RPMrel to colon tumor tissues from four patients. We saw no binding of RPMrel to normal colon tissues. In addition, RPMrel failed to stain a panel of noncolon tissues including the lungs, liver, and stomach. We further demonstrated that RPMrel coupled to the mitochondrial toxin (KLAKLAK)2 killed HT29 cells. These studies suggest that RPMrel may be a promising lead candidate in the development of a useful colon tumor diagnostic and targeted drug delivery agent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670181      PMCID: PMC1550331          DOI: 10.1016/s1476-5586(03)80046-5

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  18 in total

Review 1.  Endoscopic diagnostics.

Authors:  P R Pfau; M V Sivak
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

2.  What is the evidence that tumors are angiogenesis dependent?

Authors:  J Folkman
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

3.  Searching for peptide ligands with an epitope library.

Authors:  J K Scott; G P Smith
Journal:  Science       Date:  1990-07-27       Impact factor: 47.728

4.  The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer.

Authors:  L A Ries; P A Wingo; D S Miller; H L Howe; H K Weir; H M Rosenberg; S W Vernon; K Cronin; B K Edwards
Journal:  Cancer       Date:  2000-05-15       Impact factor: 6.860

5.  Libraries of peptides and proteins displayed on filamentous phage.

Authors:  G P Smith; J K Scott
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

6.  Isolation of a peptide for targeted drug delivery into human head and neck solid tumors.

Authors:  F D Hong; G L Clayman
Journal:  Cancer Res       Date:  2000-12-01       Impact factor: 12.701

7.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

Review 8.  Heterogeneity of human colon carcinoma.

Authors:  M G Brattain; A E Levine; S Chakrabarty; L C Yeoman; J K Willson; B Long
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

9.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

10.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.

Authors:  G P Smith
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

View more
  26 in total

Review 1.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

2.  In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging.

Authors:  Kimberly A Kelly; Matthias Nahrendorf; Amy M Yu; Fred Reynolds; Ralph Weissleder
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

Review 3.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

4.  Detection of early prostate cancer using a hepsin-targeted imaging agent.

Authors:  Kimberly A Kelly; Sunita R Setlur; Robert Ross; Rajesh Anbazhagan; Peter Waterman; Mark A Rubin; Ralph Weissleder
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 5.  High-Throughput Approaches to the Development of Molecular Imaging Agents.

Authors:  Lina Y Hu; Kimberly A Kelly; Julie L Sutcliffe
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

Review 6.  Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications.

Authors:  Justyna Bazan; Ireneusz Całkosiński; Andrzej Gamian
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

7.  In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice.

Authors:  Jessica R Newton; Kimberly A Kelly; Umar Mahmood; Ralph Weissleder; Susan L Deutscher
Journal:  Neoplasia       Date:  2006-09       Impact factor: 5.715

Review 8.  Virus-Derived Peptides for Clinical Applications.

Authors:  Mingying Yang; Kegan Sunderland; Chuanbin Mao
Journal:  Chem Rev       Date:  2017-07-19       Impact factor: 60.622

Review 9.  Targeted nanoparticles for colorectal cancer.

Authors:  Bruno A Cisterna; Nazila Kamaly; Won Il Choi; Ali Tavakkoli; Omid C Farokhzad; Cristian Vilos
Journal:  Nanomedicine (Lond)       Date:  2016-08-16       Impact factor: 5.307

10.  Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy.

Authors:  Pei-Lin Hsiung; Pei-Lei Hsiung; Jonathan Hardy; Shai Friedland; Roy Soetikno; Christine B Du; Amy P Wu; Peyman Sahbaie; James M Crawford; Anson W Lowe; Christopher H Contag; Thomas D Wang
Journal:  Nat Med       Date:  2008-03-16       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.